Close Menu

More articles about Infectious Disease

The company last month presented data showing that the test could be used to detect cancer, but more work is needed to refine the test so that it can distinguish between different types of malignancies.

Snippets: Mar 4, 2009

Premium

DNAPrint, Laboratory Corporation of America, Duke University, Lab21, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Diseases and Stroke, and more …

Lab21 gains access to a phage amplification technology that it is being used to develop rapid tests for active and drug-resistant tuberculosis.

The Plant-Associated Microbe Gene Ontology Consortium presented a vocabulary resource comprising more than 700 words focusing on microbe-host interactions. The words appear as part of eight papers is a special supplement to BMC Microbiology.

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

The company plans this year to add new markers to its HERmark breast cancer test, and will try to ink more collaborations with drug makers in order to embed its VeraTag assays in cancer drug trials.

Snippets: Feb 25, 2009

Premium

Myriad Genetics, Kinaxo Biotechnologies, Bavarian Research Foundation, European Commission, Decode Genetics, Ontario Institute for Cancer Research

The pact builds on an existing relationship between the firms to develop an influenza molecular diagnostic assay for use with a HandyLab instrument.

Bioinformatics

The $3.8 million program will back assay development, screening tools, toxicity, and elucidation of 3D structures in search of HIV treatments

IP Update: Feb 19, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

The data, analyzed from biological samples donated by GlaxoSmithKline, is available on SAEC's website for free, and the group plans to publish the associations later this year. However, an SAEC official said "it would be preliminary to develop a meaningful diagnostic chip off this data."

Snippets: Feb 18, 2009

Premium

TrimGen, US Food and Drug Administration, University of Ottawa, Monogram Biosciences

Short Reads: Feb 17, 2009

Premium

Life Technologies, Max Planck Institute for Evolutionary Anthropology, 454 Life Sciences, Applied Biosystems, Baylor College of Medicine, University of Bristol, University of Liverpool, John Innes Centre, Helicos BioSciences, Febit, and more…

Papers of Note for Jan 2009

Premium

Sequencing-Related Papers of Note, Published Jan. 2009

Despite increasing evidence that the action of some drugs is influenced by patient genetics, testing for such variants has not been widely adopted as part of standard practice, AAAS meeting attendees heard this weekend.

LabCorp becomes the first clinical lab firm in the US to offer the recently FDA-cleared HCV test.

Monogram's annual revenues jumped 44 percent. Though the firm expects mid single-digit revenue growth for 2009, it has taken measures to cut $10 million of costs from its 2009 spending.

Pages

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.